Lisata Therapeutics Inc. (LSTA) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.70 (-2.30%), Market cap $0.03B, 52-week low–high $1.86 ~ $5.04.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Financial statements, price targets, institutional (13F) holdings and related news for Lisata Therapeutics Inc. are updated in real time on BlackAll Trade.
Lisata Therapeutics Inc. trades at $1.70 (-2.30%). Real-time quotes and charts are available on BlackAll Trade.
Lisata Therapeutics Inc. has a market cap of about $0.03B.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its